86-10-69002900 globalsales@capitalbiotech.com

en

EN

- English

Solutions for Precise Healthcare Management

Solutions for Precise Healthcare Management CapitalBiotech

Precise healthcare refers to the delivery of accurate and personalized healthcare services based on individual needs. Precise healthcare solutions involve utilizing advanced diagnostic tools, evidence-based practices, and precision medicine approaches to provide the most effective and targeted treatments for patients. GWAS is to detect molecular markers of genetic variation (such as SNPs) across the whole genome and to find their genetic correlation with observable traits/diseases, the prediction and prevention of chronic diseases are of great significance. At present, scientists from various countries have carried out a large number of GWAS studies in a variety of complex diseases, and have achieved significant results in the study of genetic susceptibility genes of complex diseases such as tumors, cardiovascular and cerebrovascular diseases, autoimmunity, and immune-related diseases. As a leader in domestic biochips, CapitalBio has led or participated in GWAS research on Chinese populations across various diseases, and relevant results have been published in top international journals. By establishing a mathematical model of susceptibility loci and disease risk, the risk of these diseases can be predicted.

Types Of Precise Healthcare Solutions

The Disease Susceptibility Genetic Test-Lung Cancer

The Disease Susceptibility Genetic Test-Lung Cancer

This test is based on biochip technology, evaluates the risk of lung cancer from a genetic perspective, and provides guidance on disease prevention.

The Disease Susceptibility Genetic Test-Liver Cancer

The Disease Susceptibility Genetic Test-Liver Cancer

This test is based on biochip technology, evaluates the risk of lung cancer from a genetic perspective, and provides guidance on disease prevention.

The Disease Susceptibility Genetic Test-Stomach Cancer

The Disease Susceptibility Genetic Test-Stomach Cancer

This test is based on biochip technology, evaluates the risk of lung cancer from a genetic perspective, and provides guidance on disease prevention.

The Disease Susceptibility Genetic Test-Breast Cancer

The Disease Susceptibility Genetic Test-Breast Cancer

The test is based on biochip technology，evaluates the risk of breast cancer from the perspective of genetics and provide guidance on disease prevention.

The Disease Susceptibility Genetic Test-Colorectal Cancer

The Disease Susceptibility Genetic Test-Colorectal Cancer

This test is based on biochip technology, evaluates the risk of lung cancer from a genetic perspective, and provides guidance on disease prevention.

The Disease Susceptibility Genetic Test-Esophageal Cancer

The Disease Susceptibility Genetic Test-Esophageal Cancer

This test is based on biochip technology, evaluates the risk of lung cancer from a genetic perspective, and provides guidance on disease prevention.

The Disease Susceptibility Genetic Test-High Incidence Cancer (6 Items)

The Disease Susceptibility Genetic Test-High Incidence Cancer (6 Items)

This test is based on biochip technology, evaluates the risk of lung cancer from a genetic perspective, and provides guidance on disease prevention.

The Disease Susceptibility Genetic Test-High Incidence Cancer (10 Items)

The Disease Susceptibility Genetic Test-High Incidence Cancer (10 Items)

This test is based on biochip technology, evaluates the risk of lung cancer from a genetic perspective, and provides guidance on disease prevention.

The Disease Susceptibility Genetic Test-Cancer Screening Package (29 Items)

The Disease Susceptibility Genetic Test-Cancer Screening Package (29 Items)

This test is based on biochip technology, evaluates the risk of 29 high-incidence cancers from a genetic perspecitve, and provides guidance to disease prevention.

The Disease Susceptibility Genetic Test-Anti-Cancer Package A

The Disease Susceptibility Genetic Test-Anti-Cancer Package A

The test is based on biochip technology. By detecting susceptibility loci in the TP53 gene that are closely related to tumorigenesis, it evaluates its influence on the risk of male tumors and female tumors.

The Disease Susceptibility Genetic Test-Anti-Cancer Package C

The Disease Susceptibility Genetic Test-Anti-Cancer Package C

This test is based on biochip technology. By detecting TP53, CYP1A1 and XRCC1, it assesses their impact on the risk of tumors.

The Disease Susceptibility Genetic Test-Alzheimer's Disease

The Disease Susceptibility Genetic Test-Alzheimer's Disease

This test is based on biochip technology and evaluates the risk of Alzheimer's disease by detecting innate susceptibility genes of the human body.

The Disease Susceptibility Genetic Test-Thrombotic Disorders (5 Items)

The Disease Susceptibility Genetic Test-Thrombotic Disorders (5 Items)

This test is based on biochip technology and evaluates the risk of five thrombotic diseases from a genetic perspecitve.

The Disease Susceptibility Genetic Test-Diabetes (4 Items)

The Disease Susceptibility Genetic Test-Diabetes (4 Items)

This test is based on biochip technology, from a genetic perspective, assesses the risk of type 2 diabetes and its complications, as well as the sensitivity to hypoglycemic drugs.

The Disease Susceptibility Genetic Test-Cardiovascular Disease (14 Items)

The Disease Susceptibility Genetic Test-Cardiovascular Disease (14 Items)

This test is based on biochip technology, evaluates the risk of 14 cardiovascular and cerebrovascular diseases from a genetic perspective, and guides disease prevention.

The Disease Susceptibility Genetic Test-Chronic Disease Package (34 Items)

The Disease Susceptibility Genetic Test-Chronic Disease Package (34 Items)

This test is based on biochip technology, evaluates the risk of 34 chronic diseases from a genetic perspective and provides guidance to disease prevention.

The Disease Susceptibility Genetic Test-Chronic Disease Package (63 Items)

The Disease Susceptibility Genetic Test-Chronic Disease Package (63 Items)

This test is based on biochip technology, evaluates the risk of 63 chronic diseases from a genetic perspective and provides guidance to disease prevention.

The Disease Susceptibility Genetic Test-APOE

The Disease Susceptibility Genetic Test-APOE

The test is based on biochip technology. By detecting two gene loci that determine APOE protein polymorphism, it evaluates their impact on the risk of cardiovascular and cerebrovascular diseases, and metabolic diseases.

The Disease Susceptibility Genetic Test-ADIPO

The Disease Susceptibility Genetic Test-ADIPO

This test is based on biochip technology and evaluates the influence of these loci on cardiovascular and cerebrovascular diseases, metabolic diseases, tumors and other diseases by detecting two loci of the adiponectin gene.

The Disease Susceptibility Genetic Test-Full Package (150 Items)

The Disease Susceptibility Genetic Test-Full Package (150 Items)

This test is based on biochip technology and evaluates the risk of nearly 150 diseases in 13 categories from a genetic perspective.

The Disease Susceptibility Genetic Test-Obesity

The Disease Susceptibility Genetic Test-Obesity

This test is based on biochip technology and evaluates the genetic risk of obesity, the effect of different nutrients in the diet, different exercise methods on the weight loss effect, by detecting the genes related to the occurrence of obesity in the human body.

The Disease Susceptibility Genetic Test-High Myopia

The Disease Susceptibility Genetic Test-High Myopia

This test is based on biochip technology and evaluates the risk of high myopia by detecting innate susceptibility genes of the human body.

Metabolic Testing-Alcohol Metabolism Test

Metabolic Testing-Alcohol Metabolism Test

This test detects the genes related to alcohol metabolism in the human body and evaluates the alcohol metabolism ability of the subject.

Metabolic Testing-Tobacco Damage

Metabolic Testing-Tobacco Damage

This test detects the metabolic process of chemical substances in tobacco and the genes related to the damage mechanism to the human body.

Metabolic Testing-Alcohol Damage

Metabolic Testing-Alcohol Damage

This test detects the metabolic process of chemical substances in alcohol and the genes related to the damage mechanism in the human body.

Metabolic Testing-Food Intolerance (50 Items)

Metabolic Testing-Food Intolerance (50 Items)

It covers 9 common food categories (including eggs and dairy, grains and nuts, meat, seafood, vegetables, fruits, yeast and beverages, seasonings, and traditional Chinese medicine) based on the microarray platform. It tests a total of 50 kinds of foods for IgG antibodies, and the best dietary plan for the subjects is formulated based on the results.

Metabolic Testing-Food Intolerance (101 Items)

Metabolic Testing-Food Intolerance (101 Items)

It covers 9 common food categories (including eggs and dairy, grains and nuts, meat, seafood, vegetables, fruits, yeast and beverages, seasonings, and traditional Chinese medicine) based on the microarray platform. It tests a total of 101 kinds of foods for IgG antibodies, and the best dietary plan for the subjects is formulated based on the results.

Intestinal Flora Testing

Intestinal Flora Testing

Intestinal flora testing uses a next-generation high-throughput sequencing platform and is based on 16S rDNA sequencing technology from the Human Microbiome Project.

Why Is Disease Susceptibility Genetic Test Important？

Genes are internal factors that affect or even determine human health, and genes associated with the disease are called disease susceptibility genes. Due to the differences between the genes of different individuals, some people are naturally prone to certain diseases, that is, they carry susceptibility genotypes related to the occurrence of diseases. When these susceptible people are exposed to adverse factors in the environment, their disease incidence rate is higher than people who do not carry the disease susceptibility genotype. Therefore, during precise healthcare sequencing solutions understanding the disease susceptibility genes in the human body can help predict the risk of disease occurrence.

CapitalBiotech News & Blog

CapitalBiotech Continues to Promote the National Precision Medicine Center in Kyrgyzstan

News

CapitalBiotech Continues to Promote the National Precision Medicine Center in Kyrgyzstan

25 Jun,2025

10

Jun 2025

CapitalBiotech's DNA Rapid Detection System Shines at Securex South Africa 2025 NEWS

29

Apr 2025

Advantages of NGS Genetic Testing NEWS

22

Apr 2025

A Brief Analysis of Microfluidic Technology NEWS

globalsales@capitalbiotech.com

86-10-69002900

Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing

Copyright © CapitalBiotech Co., Ltd. All Rights Reserved.
Sitemap | Privacy Policy

86-10-69002900